91�鶹����ֱ��

In a rare but serious complication of cancer, the body’s own immune system can start attacking the brain, causing rapid-onset memory loss and cognitive deficits. What triggers this sudden biological...

Moriel Zelikowsky, Ph.D., an assistant professor of neurobiology at the Spencer Fox Eccles School of Medicine at the University of Utah, has received a 2023 McKnight Scholar Award in recognition...

91�鶹����ֱ�� scientists discovered insights into the importance of a minor cell type in the brain—microglia—in controlling anxiety-related behaviors. The findings could lead to new approaches for targeted...

A new study with mice, that could have implications for people, suggests that some decisions are hard-wired and largely beyond their control.

Children are at increased risk of stroke after COVID-19 infection, according to a new study by scientists at 91�鶹����ֱ��.

Whatever you do, don’t call them "mini-brains," say 91�鶹����ֱ�� scientists. Regardless, the seed-sized organoids—which are grown in the lab from human cells—are providing insights into the brain...

Whatever you do, don’t call them “mini-brains,” say 91�鶹����ֱ�� scientists. Regardless, the seed-sized organoids—which are grown in the lab from human cells—are providing insights into the brain...

The University of Utah College of Pharmacy’s Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $34 million contract renewal with the NIH’s National Institute of Neurological Disorders and...

Stefan M. Pulst, M.D., Dr. med., professor and chair of the Department of Neurology at 91�鶹����ֱ��, is one of nine recipients nationwide of the 2022 R35 Outstanding...

Preventing the formation of a sticky, web-like substance that can form in blood vessels after a stroke could protect the brain and lead to better outcomes for patients, studies in...

91�鶹����ֱ�� and Intermountain Healthcare are taking part in an international study to help determine if high intensity exercise can slow the progression of Parkinson’s disease.

U of U Health scientists have identified a molecule that slows cells’ production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson’s disease.